HEPARIN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for heparin sodium and what is the scope of freedom to operate?
Heparin sodium
is the generic ingredient in forty-one branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Epic Pharma Llc, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, 3M, and Cormedix, and is included in eighty-seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are forty-nine drug master file entries for heparin sodium. Twenty-one suppliers are listed for this compound.
Summary for HEPARIN SODIUM
US Patents: | 4 |
Tradenames: | 41 |
Applicants: | 35 |
NDAs: | 87 |
Drug Master File Entries: | 49 |
Finished Product Suppliers / Packagers: | 21 |
Clinical Trials: | 98 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for HEPARIN SODIUM |
What excipients (inactive ingredients) are in HEPARIN SODIUM? | HEPARIN SODIUM excipients list |
DailyMed Link: | HEPARIN SODIUM at DailyMed |
Recent Clinical Trials for HEPARIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vaneltix Pharma, Inc. | Phase 2 |
Prevail Infoworks, Inc | Phase 2 |
The First Affiliated Hospital with Nanjing Medical University | N/A |
Pharmacology for HEPARIN SODIUM
Drug Class | Anti-coagulant Unfractionated Heparin |
Anatomical Therapeutic Chemical (ATC) Classes for HEPARIN SODIUM
US Patents and Regulatory Information for HEPARIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 004570-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | PANHEPRIN | heparin sodium | INJECTABLE;INJECTION | 005264-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fresenius Kabi Usa | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017651-006 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Solopak | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 087395-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mcgaw | HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER | heparin sodium | INJECTABLE;INJECTION | 019130-002 | Dec 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER | heparin sodium | INJECTABLE;INJECTION | 019339-003 | Mar 27, 1985 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.